CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ 57,179	$ (9,002)
Adjustments to net income (loss):
Depreciation and amortization	154,638	157,685
Deferred income tax expense (benefit)	5,323	6,376
Impairments and other charges	26,456
Amortization of debt discount and deferred financing costs	2,136	2,266
Bargain purchase gain	(112,999)
Losses (gains) on debt buyback		2,576
Losses (gains) on sale of long-lived assets, net	(4,125)	4,600
Share-based compensation	4,133	4,155
Foreign currency transaction losses (gains), net	69	11,394
Mark-to-market (gain) loss on warrants	(4,212)	(5,679)
Other	1,127	543
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(29,711)	(67,201)
Inventory	10,696	(2,046)
Other current assets	(6,432)	(2,548)
Other long-term assets	373	665
Trade accounts payable and accrued liabilities	(8,575)	8,625
Income taxes payable	(4,080)	3,810
Other long-term liabilities	(4,261)	(8,980)
Net cash provided by (used for) operating activities	87,735	107,239
Cash flows from investing activities:
Purchases of investments	(183)	(7,544)
Cash acquired in stock based business combination, net of cash paid	84,429
Capital expenditures	(164,952)	(104,627)
Proceeds from sales of assets	5,791	5,502
Other	(5)	40
Net cash (used for) provided by investing activities	(74,920)	(106,629)
Cash flows from financing activities:
Reduction in debt	(177,807)	(631,043)
Debt issuance costs		(1,343)
Proceeds from revolving credit facilities	263,000	75,000
Reduction in revolving credit facilities	(85,000)	(75,000)
Payments for employee taxes on net settlement of equity awards	(2,151)	(2,634)
Dividends to common and preferred shareholders		(87)
Net cash (used for) provided by financing activities	(1,958)	(635,107)
Effect of exchange rate changes on cash and cash equivalents	(420)	(5,910)
Net increase (decrease) in cash and cash equivalents and restricted cash	10,437	(640,407)
Cash and cash equivalents and restricted cash, beginning of period	722,960	1,374,182
Cash and cash equivalents and restricted cash, end of period	733,397	733,775
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	389,652	1,057,487
Restricted cash, beginning of period	333,308	316,695
Cash and cash equivalents and restricted cash, beginning of period	722,960	1,374,182
Cash and cash equivalents, end of period	396,470	412,864
Restricted cash, end of period	$ 336,927	$ 320,911
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 733,397	$ 733,775